Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein

Theodora S. Ross, D. Gary Gilliland

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

We have previously reported that the Huntingtin interacting protein 1 (HIP1) gene is fused to the platelet-derived growth factor β receptor (PDGFβR) gene in a patient with chronic myelomonocytic leukemia. We now show that HIP1/PDGFβR oligomerizes, is constitutively tyrosine-phosphorylated, and transforms the murine hematopoietic cell line, Ba/F3, to interleukin-3- independent growth. A kinase-inactive mutant is neither tyrosine- phosphorylated nor able to transform Ba/F3 cells. Oligomerization and kinase activation required the 55-amino acid carboxyl-terminal TALIN homology region but not the leucine zipper domain. Tyrosine phosphorylation of a 130-kDa protein and STAT5 correlates with transformation in cells expressing HIP1/PDGFβR and related mutants. A deletion mutant fusion protein that contains only the TALIN homology region of HIP1 fused to PDGFβR is incapable of transforming Ba/F3 cells and does not tyrosine-phosphorylate p130 or STAT5, although it is itself constitutively tyrosine-phosphorylated. We have also analyzed cells expressing Tyr → Phe mutants of HIP1/PDGFβR in the known PDGFβR SH2 docking sites and report that none of these sites are necessary for STAT5 activation, p130 phosphorylation, or Ba/F3 transformation. The correlation of factor-independent growth of hematopoietic cells with p130 and STAT5 phosphorylation/activation in both the HIP1/PDGFβR Tyr → Phe and deletion mutational variants suggests that both STAT5 and p130 are important for transformation mediated by HIP1/PDGFβR.

Original languageEnglish (US)
Pages (from-to)22328-22336
Number of pages9
JournalJournal of Biological Chemistry
Volume274
Issue number32
DOIs
StatePublished - Aug 6 1999

Fingerprint

Platelet-Derived Growth Factor Receptors
Fusion reactions
Tyrosine
Phosphorylation
Proteins
Cells
Chemical activation
Hematopoietic Cell Growth Factors
Phosphotransferases
Genes
STAT5 Transcription Factor
Leukemia, Myelomonocytic, Chronic
Leucine Zippers
Oligomerization
Huntingtin Protein
Interleukin-3
Mutant Proteins
Amino Acids
Cell Line

ASJC Scopus subject areas

  • Biochemistry

Cite this

Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein. / Ross, Theodora S.; Gilliland, D. Gary.

In: Journal of Biological Chemistry, Vol. 274, No. 32, 06.08.1999, p. 22328-22336.

Research output: Contribution to journalArticle

@article{9369212ddd1a4573aaac4987b8af9f95,
title = "Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein",
abstract = "We have previously reported that the Huntingtin interacting protein 1 (HIP1) gene is fused to the platelet-derived growth factor β receptor (PDGFβR) gene in a patient with chronic myelomonocytic leukemia. We now show that HIP1/PDGFβR oligomerizes, is constitutively tyrosine-phosphorylated, and transforms the murine hematopoietic cell line, Ba/F3, to interleukin-3- independent growth. A kinase-inactive mutant is neither tyrosine- phosphorylated nor able to transform Ba/F3 cells. Oligomerization and kinase activation required the 55-amino acid carboxyl-terminal TALIN homology region but not the leucine zipper domain. Tyrosine phosphorylation of a 130-kDa protein and STAT5 correlates with transformation in cells expressing HIP1/PDGFβR and related mutants. A deletion mutant fusion protein that contains only the TALIN homology region of HIP1 fused to PDGFβR is incapable of transforming Ba/F3 cells and does not tyrosine-phosphorylate p130 or STAT5, although it is itself constitutively tyrosine-phosphorylated. We have also analyzed cells expressing Tyr → Phe mutants of HIP1/PDGFβR in the known PDGFβR SH2 docking sites and report that none of these sites are necessary for STAT5 activation, p130 phosphorylation, or Ba/F3 transformation. The correlation of factor-independent growth of hematopoietic cells with p130 and STAT5 phosphorylation/activation in both the HIP1/PDGFβR Tyr → Phe and deletion mutational variants suggests that both STAT5 and p130 are important for transformation mediated by HIP1/PDGFβR.",
author = "Ross, {Theodora S.} and Gilliland, {D. Gary}",
year = "1999",
month = "8",
day = "6",
doi = "10.1074/jbc.274.32.22328",
language = "English (US)",
volume = "274",
pages = "22328--22336",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "32",

}

TY - JOUR

T1 - Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein

AU - Ross, Theodora S.

AU - Gilliland, D. Gary

PY - 1999/8/6

Y1 - 1999/8/6

N2 - We have previously reported that the Huntingtin interacting protein 1 (HIP1) gene is fused to the platelet-derived growth factor β receptor (PDGFβR) gene in a patient with chronic myelomonocytic leukemia. We now show that HIP1/PDGFβR oligomerizes, is constitutively tyrosine-phosphorylated, and transforms the murine hematopoietic cell line, Ba/F3, to interleukin-3- independent growth. A kinase-inactive mutant is neither tyrosine- phosphorylated nor able to transform Ba/F3 cells. Oligomerization and kinase activation required the 55-amino acid carboxyl-terminal TALIN homology region but not the leucine zipper domain. Tyrosine phosphorylation of a 130-kDa protein and STAT5 correlates with transformation in cells expressing HIP1/PDGFβR and related mutants. A deletion mutant fusion protein that contains only the TALIN homology region of HIP1 fused to PDGFβR is incapable of transforming Ba/F3 cells and does not tyrosine-phosphorylate p130 or STAT5, although it is itself constitutively tyrosine-phosphorylated. We have also analyzed cells expressing Tyr → Phe mutants of HIP1/PDGFβR in the known PDGFβR SH2 docking sites and report that none of these sites are necessary for STAT5 activation, p130 phosphorylation, or Ba/F3 transformation. The correlation of factor-independent growth of hematopoietic cells with p130 and STAT5 phosphorylation/activation in both the HIP1/PDGFβR Tyr → Phe and deletion mutational variants suggests that both STAT5 and p130 are important for transformation mediated by HIP1/PDGFβR.

AB - We have previously reported that the Huntingtin interacting protein 1 (HIP1) gene is fused to the platelet-derived growth factor β receptor (PDGFβR) gene in a patient with chronic myelomonocytic leukemia. We now show that HIP1/PDGFβR oligomerizes, is constitutively tyrosine-phosphorylated, and transforms the murine hematopoietic cell line, Ba/F3, to interleukin-3- independent growth. A kinase-inactive mutant is neither tyrosine- phosphorylated nor able to transform Ba/F3 cells. Oligomerization and kinase activation required the 55-amino acid carboxyl-terminal TALIN homology region but not the leucine zipper domain. Tyrosine phosphorylation of a 130-kDa protein and STAT5 correlates with transformation in cells expressing HIP1/PDGFβR and related mutants. A deletion mutant fusion protein that contains only the TALIN homology region of HIP1 fused to PDGFβR is incapable of transforming Ba/F3 cells and does not tyrosine-phosphorylate p130 or STAT5, although it is itself constitutively tyrosine-phosphorylated. We have also analyzed cells expressing Tyr → Phe mutants of HIP1/PDGFβR in the known PDGFβR SH2 docking sites and report that none of these sites are necessary for STAT5 activation, p130 phosphorylation, or Ba/F3 transformation. The correlation of factor-independent growth of hematopoietic cells with p130 and STAT5 phosphorylation/activation in both the HIP1/PDGFβR Tyr → Phe and deletion mutational variants suggests that both STAT5 and p130 are important for transformation mediated by HIP1/PDGFβR.

UR - http://www.scopus.com/inward/record.url?scp=0033529599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033529599&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.32.22328

DO - 10.1074/jbc.274.32.22328

M3 - Article

VL - 274

SP - 22328

EP - 22336

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 32

ER -